| 7:45-8:00 | Self-guided orientation to online platform | ||
| 8:00-8:30 | Welcome Michael Tibollo, Associate Minister, Mental Health and Addictions, Ministry of Health Kate Hardy, Network Director, META:PHI Meldon Kahan, Medical Director, META:PHI |
||
| 8:30-9:30 | Plenary Incorporating anti-oppression praxis in your work with people who use drugs Roberta K. Timothy BA MA MEd PhD |
||
| 9:30-10:30 | Session 1A Methadone treatment in the fentanyl era: New consensus guidelines Meldon Kahan MD CCFP FRCPC Lori Regenstreif MD CCFP (AM) FCFP MScCH (AMH) CISAM |
Session 1B Resources and strategies to support vulnerable and marginalized patients in RAAM clinics Christina Henry RN BA BScN |
Session 1C Caring for health professionals with SUD Adam Newman MD FCFP (AM) CCSAM Lisa Lefebvre MDCM MPH CCFP (AM) DABAM FASAM CCSAM CMRO Mark Weiss MD MCFP (AM) |
| 10:30-10:45 | Break | ||
| 10:45-11:45 | Session 2A Co-prescribing for concurrent disorders Valerie Primeau MD FRCPC |
Session 2B RAAM innovations (1) The Alex RAAM Jennifer Eyford MSc BSc BN RN (2) Lakeridge opioid navigator Lindsay Reynolds MEd RP |
Session 2C Harm reduction for hospitalized patients and people who inject drugs Tali Cahill BScN RN Christopher Francoeur, Community Worker, Oasis Program, Sandy Hill Community Health Centre |
| 11:45-12:30 | Lunch | ||
| 12:30-2:00 | Panel Innovations in care for people with SUDs during COVID: What can we learn going forward? Moderator: Vincent Lam MD CCFP (AM) ASAM CSAM (1) Working with managed alcohol/managed stimulant programs during COVID – Michelle Klaiman MD FRCPC DABAM (2) Virtual care – Michael Roach, Regional Lead, Addictions Services, Mental Health and Addictions Programs, Health Sciences North (3) COVID-OAT changes – Tara Gomes PhD MHSc (4) Patient perspective – Malcolm Kennedy |
||
| 2:00-2:45 | Session 3A Long-acting buprenorphine options Katie Dunham BSc BScN MN NP-PHC Ken Lee MD MCFP (AM) |
Session 3B The role of peer support and lived experience in addiction medicine Josh Richardson RP RPN Psych Cert BA Hons Charles Coke, Peer Support Advocate |
Session 3C MI and brief interventions in the addictions setting Julie Henderson MD FRCPC DABAM Leslie Molnar MSW RSW |
| 2:45-3:00 | Break | ||
| 3:00-3:45 | Session 4A Case discussions: RAAM challenges and opportunities Jennifer Wyman MD CCFP FCFP DABAM MPH |
Session 4B Family-centred care Angie Hamilton LLB BCL Louise Lemieux White BScN RN |
Session 4C Contingency management Melissa Holowaty PhD MD CCFP (AM) |
| 3:45-4:00 | Regroup and wrap-up | ||
| 4:00-5:00 (optional) |
Networking A Inpatient medicine Lisa Bromley MD CCFP (AM) FCFP |
Networking B Counsellors and case managers Josh Richardson RP RPN Psych Cert BA Hons |
Networking C Rural and remote practices Tara Leary MD CCFP FCFP |
Networking D Legal/human rights issues and SUD Angie Hamilton LLB BCL Daphne Jarvis LLBN |
Networking E Fentanyl challenges Meldon Kahan MD CCFP FRCPC |
Accreditation
This conference has been certified by Continuing Professional Development, Faculty of Medicine, University of Toronto for up to 6.0 Mainpro+ credits and up to 6.0 Royal College of Physicians and Surgeons of Canada Section 1 hours.
Thank you to our conference planning committee for their input and expertise in the planning of this event:
Leslie Buckley MD MPH FRCPC
Katie Dunham BSc Hons, BScN, MN, NP-PHC
Kate Hardy MSW RSW
Christina Henry RN BScN BA
Elizabeth Shouldice MD CCFP(EM) FCFP MPH
Jennifer Wyman MD CCFP FCFP DABAM MPH
Maria Zhang BScPhrm, PhmD
| Session 1A Methadone treatment in the fentanyl era: New consensus guidelines Meldon Kahan MD CCFP FRCPC Lori Regenstreif MD CCFP (AM) FCFP MScCH (AMH) CISAM |
Session 1B Resources and strategies to support vulnerable and marginalized patients in RAAM clinics Christina Henry RN BA BScN |
Session 1C Caring for health professionals with SUD Adam Newman MD FCFP (AM) CCSAM Lisa Lefebvre MDCM MPH CCFP (AM) DABAM FASAM CCSAM CMRO Mark Weiss MD MCFP (AM) |
| Session 2A Co-prescribing for concurrent disorders Valerie Primeau MD FRCPC |
Session 2B RAAM innovations (1) Lakeridge opioid navigator: Lindsay Reynolds MEd RP (2) The Alex RAAM: Jennifer Eyford MSc BSc BN RN |
Session 2C Harm reduction for hospitalized patients and people who inject drugs Tali Cahill BScN RN Christopher Francoeur, Community Worker, Oasis Program, Sandy Hill Community Health Centre |
| Panel Innovations in care for people with SUDs during COVID: What can we learn going forward? Moderator: Vincent Lam MD CCFP (AM) ASAM CSAM (1) Working with managed alcohol/managed stimulant programs during COVID – Michelle Klaiman MD FRCPC DABAM (2) Virtual care – Michael Roach, Regional Lead, Addictions Services, Mental Health and Addictions Programs, Health Sciences North (3) COVID-OAT changes – Tara Gomes PhD MHSc (4) Patient perspective – Malcolm Kennedy |
||
| Session 3A Long-acting buprenorphine options Katie Dunham BSc BScN MN NP-PHC Ken Lee MD MCFP (AM) |
Session 3B The role of peer support and lived experience in addiction medicine Josh Richardson RP RPN Psych Cert BA Hons Charles Coke, Peer Support Advocate |
Session 3C MI and brief interventions in the addictions setting Julie Henderson MD FRCPC DABAM Leslie Molnar MSW RSW |
| Session 4A Case discussions: RAAM challenges and opportunities Jennifer Wyman MD CCFP FCFP DABAM MPH |
Session 4B Family-centred care Angie Hamilton LLB BCL Louise Lemieux White BScN RN |
Session 4C Contingency management Melissa Holowaty PhD MD CCFP (AM) |